PortfoliosLab logoPortfoliosLab logo
FBIOX vs. SHSAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FBIOX vs. SHSAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Biotechnology Portfolio (FBIOX) and BlackRock Health Sciences Opportunities Portfolio (SHSAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FBIOX achieves a 11.03% return, which is significantly higher than SHSAX's -1.61% return. Over the past 10 years, FBIOX has outperformed SHSAX with an annualized return of 11.69%, while SHSAX has yielded a comparatively lower 10.05% annualized return.


FBIOX

1D
2.80%
1M
6.82%
YTD
11.03%
6M
8.61%
1Y
58.91%
3Y*
20.04%
5Y*
6.76%
10Y*
11.69%

SHSAX

1D
1.37%
1M
1.76%
YTD
-1.61%
6M
-2.20%
1Y
17.76%
3Y*
6.60%
5Y*
3.86%
10Y*
10.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FBIOX vs. SHSAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FBIOX
Fidelity Select Biotechnology Portfolio
11.03%36.38%7.26%10.09%-15.87%-12.26%38.62%36.12%-10.92%27.87%
SHSAX
BlackRock Health Sciences Opportunities Portfolio
-1.61%15.85%3.73%3.59%-5.94%11.88%19.44%25.27%7.93%24.74%

Correlation

The correlation between FBIOX and SHSAX is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.74

Correlation (3Y)
Calculated over the trailing 3-year period

0.72

Correlation (5Y)
Calculated over the trailing 5-year period

0.71

Correlation (10Y)
Calculated over the trailing 10-year period

0.75

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2000

0.80

The correlation between FBIOX and SHSAX has been stable across timeframes, ranging from 0.71 to 0.80 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FBIOX vs. SHSAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBIOX
FBIOX Risk / Return Rank: 8888
Overall Rank
FBIOX Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
FBIOX Sortino Ratio Rank: 8484
Sortino Ratio Rank
FBIOX Omega Ratio Rank: 7373
Omega Ratio Rank
FBIOX Calmar Ratio Rank: 9898
Calmar Ratio Rank
FBIOX Martin Ratio Rank: 9797
Martin Ratio Rank

SHSAX
SHSAX Risk / Return Rank: 2323
Overall Rank
SHSAX Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
SHSAX Sortino Ratio Rank: 2525
Sortino Ratio Rank
SHSAX Omega Ratio Rank: 2121
Omega Ratio Rank
SHSAX Calmar Ratio Rank: 2727
Calmar Ratio Rank
SHSAX Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBIOX vs. SHSAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and BlackRock Health Sciences Opportunities Portfolio (SHSAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FBIOXSHSAXDifference
Sharpe ratioReturn per unit of total volatility

+1.47

Sortino ratioReturn per unit of downside risk

+1.70

Omega ratioGain probability vs. loss probability

1.44

1.22

+0.22

Calmar ratioReturn relative to maximum drawdown

7.66

1.82

+5.84

Martin ratioReturn relative to average drawdown

23.32

4.39

+18.94

FBIOX vs. SHSAX - Sharpe Ratio Comparison

The current FBIOX Sharpe Ratio is 2.74, which is higher than the SHSAX Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of FBIOX and SHSAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FBIOX vs. SHSAX - Drawdown Comparison

The maximum FBIOX drawdown since its inception was -71.98%, which is greater than SHSAX's maximum drawdown of -35.49%. Use the drawdown chart below to compare losses from any high point for FBIOX and SHSAX.


Loading charts...

Drawdown Indicators


FBIOXSHSAXDifference

Max Drawdown

Largest peak-to-trough decline

-71.98%

-35.49%

-36.49%

Max Drawdown (1Y)

Largest decline over 1 year

-7.62%

-9.87%

+2.25%

Max Drawdown (3Y)

Largest decline over 3 years

-27.83%

-16.08%

-11.75%

Max Drawdown (5Y)

Largest decline over 5 years

-44.87%

-17.99%

-26.88%

Max Drawdown (10Y)

Largest decline over 10 years

-48.66%

-28.36%

-20.30%

Current Drawdown

Current decline from peak

0.00%

-4.44%

+4.44%

Average Drawdown

Average peak-to-trough decline

-23.60%

-6.17%

-17.43%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.50%

4.09%

-1.59%

Volatility

FBIOX vs. SHSAX - Volatility Comparison

Fidelity Select Biotechnology Portfolio (FBIOX) has a higher volatility of 8.04% compared to BlackRock Health Sciences Opportunities Portfolio (SHSAX) at 5.09%. This indicates that FBIOX's price experiences larger fluctuations and is considered to be riskier than SHSAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FBIOXSHSAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.04%

5.09%

+2.95%

Volatility (6M)

Calculated over the trailing 6-month period

17.08%

10.73%

+6.35%

Volatility (1Y)

Calculated over the trailing 1-year period

21.36%

14.22%

+7.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.03%

14.44%

+10.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.26%

16.57%

+9.69%

FBIOX vs. SHSAX - Expense Ratio Comparison

FBIOX has a 0.69% expense ratio, which is lower than SHSAX's 1.09% expense ratio.


Dividends

FBIOX vs. SHSAX - Dividend Comparison

FBIOX's dividend yield for the trailing twelve months is around 6.06%, less than SHSAX's 10.81% yield.


PositionTTM20252024202320222021202020192018201720162015
FBIOX
Fidelity Select Biotechnology Portfolio
6.06%2.47%1.21%0.45%0.00%14.48%19.46%8.89%11.18%1.41%3.42%6.71%
SHSAX
BlackRock Health Sciences Opportunities Portfolio
10.81%10.63%9.18%3.84%7.44%9.20%4.34%3.89%8.56%3.53%2.43%12.58%

Frequently Asked Questions


FBIOX and SHSAX have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FBIOX has higher volatility (8.04%) compared to SHSAX (5.09%). In terms of maximum drawdown, FBIOX dropped -71.98% vs SHSAX's -35.49%.

FBIOX currently has the higher Sharpe Ratio (2.74 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FBIOX and SHSAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer